What does Hemab Therapeutics Holdings, Inc. (COAG) do?

Hemab Therapeutics Holdings, Inc. (COAG) is a publicly traded company in the Healthcare sector.

What sector does COAG operate in?

Hemab Therapeutics Holdings, Inc. operates in the Healthcare, specifically within the Biotechnology industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find COAG earnings analysis?

AlphaOS publishes an earnings intelligence page for Hemab Therapeutics Holdings, Inc. (COAG) covering results, guidance context, and AI-assisted analysis. See /stocks/COAG/earnings. Content is for research and education — not investment advice.

COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

$38.25Sep 22, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Strong evidence · 3 sources

Why it matters

Hemab Therapeutics Holdings, Inc. execution reads as strong on proprietary earnings and initiative evidence.

Why it matters: Breakthrough Therapy Designation for sutacimig (Q2 FY2026).

ExecutionStrong

CapitalReinvesting

2 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Breakthrough Therapy Designation for sutacimig (Q2 FY2026)
Orphan Drug Designation for sutacimig (Q2 FY2026)

Pipeline evidence · 0d ago

COAG's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on COAG.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated September 30, 2026

What happened recently for Hemab Therapeutics Holdings, Inc. (COAG) — events, not interpretation.

Event: Last session September 22, 2026 at $38.25.
Source: Market data

Research & analysis only — not investment advice.

Building company intelligence…

Hemab Therapeutics Holdings, Inc. (COAG)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Hemab Therapeutics Holdings, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotechnology
Market cap:: $1.79B

COAG earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Hemab Therapeutics Holdings, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.